Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India
· Delayed Price · Currency is INR 479.60
+5.25 (1.11%)
At close: Mar 9, 2026
NSE:AKUMS Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | - | 3,382 | -40.35 | 948.55 | -2,525 | 1,227 |
| Depreciation & Amortization | - | 1,509 | 1,235 | 1,112 | 923.9 | 681.72 |
| Other Amortization | - | 25.16 | 21.35 | 16.34 | 22.89 | 16.69 |
| Loss (Gain) From Sale of Assets | - | 1.12 | 11.78 | 1.75 | 20.66 | 4.04 |
| Asset Writedown & Restructuring Costs | - | -38.27 | -1.38 | 675.14 | 119.22 | 100 |
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.77 |
| Loss (Gain) on Equity Investments | - | - | - | 2.03 | -2.03 | -3.47 |
| Provision & Write-off of Bad Debts | - | 294.11 | 134.01 | 43.14 | 188.62 | 139.94 |
| Other Operating Activities | - | -855.91 | 3,123 | -689.05 | 5,086 | 552.09 |
| Change in Accounts Receivable | - | 341.05 | -32.32 | 349.11 | -3,718 | 361.48 |
| Change in Inventory | - | -505.71 | 837.29 | -73.47 | -2,926 | -315.41 |
| Change in Accounts Payable | - | 1,192 | -291.96 | -183.69 | 2,505 | -819.04 |
| Change in Other Net Operating Assets | - | -692.95 | -14.34 | -435.29 | 623 | -638.18 |
| Operating Cash Flow | - | 4,652 | 4,983 | 1,766 | 318.54 | 1,306 |
| Operating Cash Flow Growth | - | -6.64% | 182.09% | 454.50% | -75.61% | - |
| Capital Expenditures | - | -2,723 | -3,114 | -3,288 | -2,576 | -828.1 |
| Sale of Property, Plant & Equipment | - | 85.47 | 249.93 | 421.47 | 19.24 | 9.38 |
| Cash Acquisitions | - | - | - | -16.2 | -110.02 | -605 |
| Investment in Securities | - | -3,091 | -634.75 | -449.53 | 247.07 | 254.6 |
| Other Investing Activities | - | 249.86 | 121.02 | 303.9 | 46.31 | 66.77 |
| Investing Cash Flow | - | -5,478 | -3,304 | -3,047 | -2,348 | -1,094 |
| Short-Term Debt Issued | - | - | - | 485.79 | 2,524 | - |
| Long-Term Debt Issued | - | - | 102.94 | 1,402 | 200.19 | 11.61 |
| Total Debt Issued | - | - | 102.94 | 1,887 | 2,724 | 11.61 |
| Short-Term Debt Repaid | - | -3,540 | -236.3 | - | - | -396.55 |
| Long-Term Debt Repaid | - | -1,760 | -442.72 | -237.56 | -274.92 | -479.5 |
| Total Debt Repaid | - | -5,301 | -679.02 | -237.56 | -274.92 | -876.05 |
| Net Debt Issued (Repaid) | - | -5,301 | -576.08 | 1,650 | 2,450 | -864.44 |
| Issuance of Common Stock | - | 6,374 | - | - | - | - |
| Other Financing Activities | - | -345.08 | -504.13 | -404.43 | -89.1 | -50.18 |
| Financing Cash Flow | - | 727.88 | -1,080 | 1,245 | 2,360 | -914.62 |
| Miscellaneous Cash Flow Adjustments | - | - | -3.81 | - | - | 5.11 |
| Net Cash Flow | - | -98.59 | 594.42 | -35.31 | 330.72 | -697.22 |
| Free Cash Flow | - | 1,929 | 1,869 | -1,522 | -2,257 | 478.04 |
| Free Cash Flow Growth | - | 3.23% | - | - | - | - |
| Free Cash Flow Margin | - | 4.68% | 4.47% | -4.16% | -6.14% | 1.75% |
| Free Cash Flow Per Share | - | 12.89 | 13.06 | -10.64 | -15.78 | 3.34 |
| Cash Interest Paid | - | 345.08 | 504.13 | 404.43 | 89.1 | 50.18 |
| Cash Income Tax Paid | - | 812.35 | 624.2 | 970.63 | 548.18 | 455.54 |
| Levered Free Cash Flow | - | 1,082 | 794.71 | -1,950 | -2,550 | - |
| Unlevered Free Cash Flow | - | 1,272 | 1,109 | -1,662 | -2,447 | - |
| Change in Working Capital | - | 334.69 | 498.67 | -343.34 | -3,516 | -1,411 |
Source: S&P Capital IQ. Standard template. Financial Sources.